Introduction
It is now recognized that the renin-angiotensin system plays an important role in the pathogenesis of atherosclerotic and hypertensive cardiovascular diseases. Inhibiting the reninangiotensin system by angiotensin-converting enzyme inhibitors or angiotensin II (Ang II) type 1 (AT1) receptor blockers is a practical target for therapy in patients with cardiovascular disease (1) (2) (3) (4) . The central importance of the renin-angio-tensin system in atherogenesis has been proven in AT1a receptor deficient mice when atherosclerosis was induced by hyperlipidemia (5) and Ang II infusion (6) . We also reported that diabetes-induced acceleration of atherosclerosis was blunted in AT1a −/− apolipoprotein E-knockout (ApoE −/− ) mice (authors' unpublished observation). Infusion of Ang II into hypercholesterolemic mice dramatically accelerates the atherosclerotic process, leading to the development of extensive atherosclerotic plaque formation (7) . We have recently demonstrated that blockade of the monocyte chemoattractant protein-1 (MCP-1) pathway limits Ang II-induced progression and destabilization of atherosclerotic lesions in hyperlipidemic ApoE −/− mice (8) . Therefore, Ang II-mediated acceleration of atherogenesis is characterized by the recruitment and activation of monocytes/macrophages and the degradation of elastin and collagen layers, suggesting that Ang II changes the lesion composition into a more destabilized phenotype. Thus, identification of the critical inflammatory pathway involved in Ang II-induced atherosclerosis might aid in the development of novel therapeutic strategies to reduce atherothrombotic events. The role of Ang II and/or AT1 receptors in atherogenesis may be more complex. Ang II is thought to accelerate atherogenesis by stimulating AT1 receptors in the multiple cell types of atherosclerotic lesions, such as endothelial cells, smooth muscle cells, and leukocytes. Activation of the Ang II-AT1 receptor pathway mediates recruitment and activation of monocytes (9) , endothelial migration and angiogenesis (10) , and migration/proliferation of vascular smooth muscle cells (11, 12) . It is impossible, however, to dissect the relative pathobiologic role of leukocytes vs. non-leukocyte cells in the arterial wall using the systemic absence of AT1a receptors or AT1 receptor blockers. We previously reported that 1) Ang II upregulates the MCP-1 receptor (C-C chemokine receptor 2 [CCR2]) in circulating monocytes (13) and 2) Ang II-induced vascular remodeling and atherosclerosis were blunted in donor CCR2 deficient ApoE −/− mice created by bone marrow transplantation (BMT) (13, 14) . Recently, Cassis et al. (15) and Fukuda et al. (16) independently reported that 1) Ang IIinduced atherosclerosis was partly reduced in mice with bone marrow AT1a receptor deficiency and 2) host AT1a receptors are also important for the formation of Ang II-induced atherosclerosis. In these studies, their analysis was focused on the degree of atherosclerotic plaque formation. In contrast, the underlying mechanisms by which AT1a receptors on the bone marrow cells vs. those on host vascular wall cells mediate atherosclerotic lesion formation remained unclarified. The aim of this study was to address the relative roles of AT1a receptors in the bone marrow vs. the host arterial wall in Ang II-induced atherogenesis of hyperlipidemic ApoE (14) . All mice were fed a normal diet and given water ad libitum.
Bone Marrow Transplantation
The study protocol was reviewed and approved by the Committee on the Ethics of Animal Experiments, Kyushu University Graduate School of Medical Sciences.
BMT was performed as described previously (13, 14) . In brief, bone marrow cells were harvested from the femurs and tibias of either AT1a 
Staining of Atherosclerotic Lesions and Morphometric Analysis
To evaluate atherosclerotic lesions, the aorta was stained with oil red O solution for 10 min at 37°C, as previously described (13, 18, 19) . The whole aorta from aortic arch to iliac bifurcation was excised and opened longitudinally. Color images were taken with a digital microscope and atherosclerotic lesion area was quantified using Scion Image software (Scion Corporation, Frederick, USA). Lesion area was determined by calculating the percentage of oil red O staining area relative to the total area of the aortic endothelial surface.
Histopathology and Immunohistochemistry
For immunohistochemical analysis, serial paraffin or frozen sections of the aortic root were prepared as described previously (13, 14) . Briefly, the aortic root was harvested from the heart and fixed overnight in 10% buffered-formalin. After fixation, the tissue was embedded in paraffin or frozen with OCT compound. Serial cross sections (6 μm thick) throughout the entire length of the aortic root were used for analysis. The sections were subjected to immunostaining using rat antimouse macrophage monoclonal antibodies (Mac-3; BD Pharmingen, San Diego, USA), goat anti-mouse MCP-1 antibodies (R&D Systems Inc., Minneapolis, USA), and antihuman vascular cell adhesion molecule 1 (VCAM-1) antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, USA). The respective non-immune IgGs were used as negative controls.
The sections were incubated with biotinylated goat anti-rat IgG or rabbit anti-goat IgG (Nichirei, Tokyo, Japan), followed by diaminobenzidine (DAB) for visualization. The sections were then counterstained with Mayer's hematoxylin. The number of macrophages accumulated in the aortic root Data are mean±SEM. After collection of total bone marrow cells from tibia, cells were incubated with phycoerythrin conjugated antilineage marker antibody. The marker positive ratio was determined by flow cytometry (n=3 each). AT1a, angiotensin II type 1a; ApoE, apolipoprotein E. 
AT1a, angiotensin II type 1a; PBS, phosphate-buffered saline; Ang II, angiotensin II. Data are mean±SEM. *p<0.01 vs. PBS.
lesion and the MCP-1 staining area was estimated. Analysis was performed using a microscope with a computerized, digital image analysis system and Scion Image Software.
Abdominal Macrophage Chemotaxis Assay
Abdominal fluid that contains macrophages was harvested 4 d after intra-peritoneal injection of thioglycolate. Macrophage migration was measured in 96-well chemotaxis chambers (Neuro Probe Inc., Gaithersburg, USA). MCP-1 (50 ng/mL) in RPMI 1640 was added to the lower wells and the isolated macrophages (1 × 10 7 cells/mL) were placed in the upper wells. After incubation for 90 min at 37°C, the upper surface of the membrane was washed with PBS and the migrated cells on the lower surface were counted after staining with trypan blue. The number of cells per field was counted. All assays were performed in triplicate.
Detection of Superoxide Production
The thoracic aortas were excised and snap frozen with OCT compound. The intact sections (20 μm thick) from the arterial segments were enzymatically unfixed and simultaneously incubated with dihydroethidium (DHE, 20 μm/L) in PBS for 30 min at 37°C in a chamber protected from the light, as previously described (20) . DHE is oxidized to ethidium bromide in the presence of superoxide, which intercalates into nuclear DNA and causes red fluorescence. The fluorescence was visualized by fluorescence microscopy using an excitation wavelength of 543-nm and a 585-nm long-pass filter.
Statistics
All data are reported as the mean±SEM. Statistical analysis of differences was performed by ANOVA followed by Bonferroni's correction for multiple comparisons. p values < 0.05 were considered to be statistically significant.
Results

Generation of the Four Groups of Chimeric Mice
We examined the bone marrow from donor AT1a +/+ ApoE
and AT1a −/− ApoE −/− mice by flow cytometry and found that there were no significant differences between these mice with regard to leukocyte composition (granulocytes, monocytes/ macrophages, T cells, and B cells) ( −/− recipient mice (Table 2 ). There were no significant differences in serum cholesterol, triglyceride, or body weight among the groups infused with saline or Ang II ( Table 2) .
Role of AT1a Receptors in the Host Arterial Wall vs. the Bone Marrow in Ang II-Induced Atherogenesis
As we have reported previously (13, 14) , chronic Ang II infusion induces atherosclerotic lesions in AT1a +/+ recipients whose bone marrow was reconstituted with donor AT1a +/+ bone marrow. The percentages of plaque areas in the mice infused with PBS or Ang II were 1.2±0.2 and 5.3±0.8%, respectively. Ang II infusion also induced atherosclerotic lesions in AT1a +/+ recipient mice whose bone marrow was reconstituted with donor AT1a −/− bone marrow. The degrees of Ang II-induced atherosclerosis were similar between these two groups (Fig. 1A) . By contrast, Ang II did not induce significant atherosclerotic lesion formation in AT1a −/− mice that received donor AT1a +/+ or AT1a −/− bone marrow (Fig. 1B) .
Macrophage infiltration is a hallmark of dyslipidemia, hypertension-induced atherogenesis, and atherosclerosis in Ang II infusion model animals. We examined the degree of macrophage infiltration into aortic atherosclerotic lesions by immunohistochemistry for a macrophage marker (Mac-3). Ang II infusion induced remarkable macrophage infiltration in the aortic neointima in AT1a +/+ mice that received donor AT1a +/+ or AT1a −/− bone marrow. As summarized in Fig. 2B , the severity of macrophage infiltration was equivalent, irrespective of the presence of bone marrow AT1a receptor. By contrast, Ang II-induced macrophage infiltration was blunted in AT1a −/− recipient mice, again irrespective of the presence of bone marrow AT1a receptor (Fig. 2) .
Ang II-Induced Superoxide Production and MCP-1 Induction in Chimeric Mice
Ang II in known to cause superoxide production in vascular smooth muscle cells that may activate redox-dependent signals that regulate inflammatory molecules including MCP-1 and VCAM-1 (14, 21, 22) . To verify the possible mechanisms by which host AT1a receptor accelerates Ang II-induced macrophage infiltration, we examined reactive oxygen species (ROS) generation as well as the expression of MCP-1 and VCAM-1 1 week after Ang II infusion was started (when atherosclerotic changes were hardly observed). DHE fluorescence was observed in the media of host AT1a +/+ mice, irrespective of the presence of donor AT1a receptor, which was blunted in host AT1a −/− mice (Fig. 3) . At this time point, the majority of ROS-producing cells are considered to be smooth muscle cells, because few macrophages infiltrate into the vascular wall and vascular remodeling has not occurred. The presence/absence of bone marrow AT1a receptor did not affect ROS generation (Fig. 3B) . No apparent DHE fluorescence was detected in the aorta from PBS-infused animals (data not shown). As expected, Ang II caused MCP-1 induction in the medial smooth muscle cells and VCAM-1 expression in the intimal monolayer of host AT1a +/+ mice. The induction of these molecules was blunted in host AT1a −/− mice (Fig. 3) , whereas no MCP-1 or VCAM-1 staining was detected in the media of aorta from PBS-infused animals (data not shown).
Fig. 1. Role of AT1a receptors in host-derived cells and in bone marrow-derived cells in Ang II-induced atherosclerosis. A: Photomicrographs of the intraluminal surface of the whole aorta from the aortic arch to the iliac bifurcation stained with oil red O in AT1a
Preserved MCP-1-Mediated Macrophage Chemotaxis in AT1a
-/-
ApoE -/-Mice In Vitro
To examine effect of AT1a receptor deficiency on macrophage function, the chemotactic response of abdominal cavity macrophages to MCP-1 was evaluated in wild-type, CCR2 −/− , AT1a +/+ ApoE −/− , and AT1a −/− ApoE −/− mice. As expected, the chemotactic response was blunted in macrophages from CCR2 −/− mice. In contrast, the chemotaxis capacity was preserved in AT1a +/+ ApoE −/− and AT1a −/− ApoE −/− mice (Fig. 4) .
Discussion
BMT experiments provide a useful approach to dissect the role of bone marrow-derived cells and host arterial wall cells in the pathogenesis of vascular diseases. In our present study, we found that Ang II-induced atherogenesis was not affected by the presence or absence of AT1a receptors in donorderived bone marrow. By contrast, recent studies using BMT (15, 16) have shown that AT1a receptor deficiency in donor bone marrow partially but significantly suppressed Ang IIinduced atherosclerosis in host AT1a +/+ mice. Although the precise mechanism remains unclarified, it is possible that bone marrow AT1a receptor regulates monocyte chemotactic function. We have previously reported that CCR2 expression and activity were upregulated in circulatory monocytes in Ang II-infused mice. However, CCR2 expression and activity were blunted by treatment with an AT1 receptor blocker or in AT1a receptor deficient mice (14) . Other studies have shown that CCR2 on monocytes is essential in mediating monocyte infiltration and subsequent atherosclerosis induced by a high-fat diet (23) or by Ang II infusion (13) . Thus, AT1a receptor deficiency in donor bone marrow may suppress monocyte recruitment through MCP-1/CCR2 signaling. However, in our present study, AT1a receptor deficiency in the bone marrow did not affect Ang II-induced macrophage infiltration or atherosclerotic plaque development. This result suggests a minor role of AT1a receptors in bone marrowderived cells in Ang II-induced atherogenesis in this model. In consensus with these results, we showed that AT1a deficiency did not affect monocyte chemotaxis in response to MCP-1, which was not examined in the previous studies (15, 16) . One explanation for the difference between studies is that we used less atherogenic stimuli (normal diet, Ang II 1. (16) . We confirmed complete repopulation of leukocytes 4 weeks after BMT by FISH experiments. The extent of atherosclerotic lesions in control BMT mice was equivalent to that of ApoE −/− mice that were administered Ang II (7). We have also previously shown that repopulated bone marrow-derived monocytes with or without CCR2 determined Ang II-induced atherosclerosis (13) , suggesting that repopulated monocytes are sufficiently functional to form Ang II-induced atherosclerosis after BMT using our protocol. However, it is still possible that different leukocyte maturity involving the reninangiotensin system may affect the results. The most remarkable finding of our present study is that (15, 16) ; however, we further extended the knowledge of the underlying mechanisms by examining the effect of host AT1a deficiency at 7 d after the initiation of Ang II infusion. We found that host AT1a receptor contributes to superoxide production and MCP-1 expression in the media and VCAM-1 expression in the endothelial cells during the initial phase of Ang II-induced atherogenesis. Vascular smooth muscle cells are considered the main producers of MCP-1 because few macrophages infiltrate into the vascular wall at this time point. It is notable that these changes, including the changes in MCP-1 expression, took place before the infiltration of monocytes/macrophages that were observed later time point, when bone marrow-derived macrophages act as a major source of MCP-1 (14, 16) . Ang II is known to activate NAD(P)H oxidase in vascular smooth muscle cells, which increases oxidative stress and subsequent redox-dependent signaling, thus leading to inflammation and proliferation of vascular cells (21, (24) (25) (26) . These mechanisms are proven to be critical in several forms of vascular pathogenesis (8, 18, 19, 27, 28) , and the present study suggests that the AT1a receptor in the vascular wall cells is essential for initiating this process during Ang II-induced atherogenesis. Host AT1a −/− mice did not show a pressor response to Ang II, which may contribute to the attenuation of atherogenesis. It is unlikely that the lack of a pressor response to Ang II contributed primarily to the observed effect of AT1a deficiency in the host artery during atherogenesis because it is well established that Ang II accelerates atherosclerosis independent of the pressor response in hyperlipidemic mice (5) . There remains a possibility that AT1a receptors existing in cell types other than those that are bone marrow-derived may affect the results because we used systemic AT1a receptor deficient mice as recipients. Vascular smooth muscle or endothelium selective AT1a receptor deficient mice are necessary as recipients to elucidate the role of each cell type.
Fig. 4. Preserved MCP-1-induced chemotaxis in AT1a
In conclusion, the present study demonstrated that AT1a receptors in the host artery, rather than bone marrow-derived cells, are essential for the initiation of Ang II-induced atherogenesis. AT1a receptors in host arterial wall cells regulate the expression of MCP-1 and VCAM-1, possibly via increased oxidative stress, and provide an inflammatory condition that in turn leads to monocyte/macrophage recruitment to the vascular wall and atherosclerotic plaque formation. These findings provide another explanation for the pleiotropy of angiotensin-converting enzyme inhibitors and/or AT1 receptor blockers beyond their effects on blood pressure.
